Co-occurrence of early diabetes-related complications in adolescents and young adults with type 1 diabetes: an observational cohort study
- PMID: 30409691
- PMCID: PMC6295346
- DOI: 10.1016/S2352-4642(18)30309-2
Co-occurrence of early diabetes-related complications in adolescents and young adults with type 1 diabetes: an observational cohort study
Abstract
Background: One in three adolescents and young adults with type 1 diabetes have at least one early diabetes-related complication or comorbidity. We aimed to examine the prevalence and pattern of co-occurring complications in this population, as well as the related risk factors.
Methods: This observational cohort study includes data from individuals diagnosed with type 1 diabetes before age 20 years who participated in the SEARCH for Diabetes in Youth Study across five sites in the USA. We assessed sociodemographic and metabolic risk factors at baseline and at follow-up, and diabetes complications at follow-up. A frequency analysis was done to examine the difference in observed versus expected prevalence (calculated using a contingency table assuming independence across cells) of co-occurring complications or comorbidities. A cluster analysis was done to identify unique clusters of participants based on demographic characteristics and metabolic risk factors.
Findings: 1327 participants who completed the follow-up visit were included in the frequency analysis. The mean age was 10·1 (SD 3·9) years at the time of type 1 diabetes diagnosis and 18·0 (4·1) years at follow-up. At a mean diabetes duration of 7·8 [SD 1·9] years, co-occurrence of any two or more complications was observed in 78 (5·9%) participants, more frequently than expected by chance alone (58 [4·4%], p=0·015). Specifically, the complications that co-occurred more frequently than expected were retinopathy and diabetic kidney disease (11 [0·8%] vs three [0·2%]; p=0·0007), retinopathy and arterial stiffness (13 [1·0%] vs four [0·3%]; p=0·0016), and arterial stiffness and cardiovascular autonomic neuropathy (24 [1·8%] vs 13 [1·0%]; p=0·015). We identified four unique clusters characterised by progressively worsening metabolic risk factor profiles (longer duration of diabetes and higher glycated haemoglobin, non-HDL cholesterol, and waist-to-height ratio). The prevalence of at least two complications increased across the clusters (six [2·3%] of 261 in the low-risk cluster, 32 [6·3%] of 509 in the moderate-risk cluster, 28 [8%] of 348 in the high-risk cluster, and five [20·8%] of 24 in the highest-risk cluster). Compared with the low-risk and moderate-risk clusters, the high-risk and highest-risk clusters were characterised by a lower proportion of participants who were non-Hispanic white, and a higher proportion of participants who had a household income below US$50 000 and did not have private health insurance.
Interpretation: Early complications co-occur in adolescents and young adults with type 1 diabetes more frequently than expected. Identification of individuals with adverse risk factors could enable targeted behavioural or medical interventions that reduce the likelihood of early development of lifelong diabetes-related morbidity.
Funding: US Centers for Disease Control and Prevention, US National Institutes of Health.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Figures
Comment in
-
Type 1 diabetes: new and fellow travellers.Lancet Child Adolesc Health. 2019 Jan;3(1):4-6. doi: 10.1016/S2352-4642(18)30337-7. Epub 2018 Nov 6. Lancet Child Adolesc Health. 2019. PMID: 30409690 No abstract available.
References
Publication types
MeSH terms
Grants and funding
- P30 DK057516/DK/NIDDK NIH HHS/United States
- UC4 DK108173/DK/NIDDK NIH HHS/United States
- U01 DP000247/DP/NCCDPHP CDC HHS/United States
- U18 DP002710/DP/NCCDPHP CDC HHS/United States
- U18 DP006134/DP/NCCDPHP CDC HHS/United States
- UL1 TR000154/TR/NCATS NIH HHS/United States
- U18 DP002714/DP/NCCDPHP CDC HHS/United States
- U01 DP000248/DP/NCCDPHP CDC HHS/United States
- U01 DP000244/DP/NCCDPHP CDC HHS/United States
- U18 DP002709/DP/NCCDPHP CDC HHS/United States
- P30 DK056350/DK/NIDDK NIH HHS/United States
- UL1 TR000077/TR/NCATS NIH HHS/United States
- UL1 TR000423/TR/NCATS NIH HHS/United States
- U01 DP000250/DP/NCCDPHP CDC HHS/United States
- U18 DP002708/DP/NCCDPHP CDC HHS/United States
- P30 DK017047/DK/NIDDK NIH HHS/United States
- UL1 TR001425/TR/NCATS NIH HHS/United States
- UL1 TR002319/TR/NCATS NIH HHS/United States
- U01 DP000246/DP/NCCDPHP CDC HHS/United States
- U01 DP000254/DP/NCCDPHP CDC HHS/United States
LinkOut - more resources
Full Text Sources
Medical
